Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Stiff Man: A Case Study in Ankylosing Spondylitis

Charles Radis, DO  |  Issue: July 2017  |  July 12, 2017

“Can you touch your toes without bending your knees?” I squatted down behind him and placed my thumbs over the upper aspect of his sacroiliac joints. “Wait, I’m going to put two marks on your back before you bend forward.”

Michael reached for the floor, but his fingertips extended only to his mid-calves. “Not so good,” I noted. “Can you try that again? Keep your knees straight and give me your best effort.” This time, I measured the distance that his lumbar spine distracted between the two points I had marked. It barely budged. The test, a Schober’s maneuver, measured 1 cm. Clearly abnormal.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

I hung the MRI up on the view box and agreed that the changes of congenital spinal stenosis were minimal. But where the MRI image extended into the sacroiliac joints was the answer. Both sides of the SI joints demonstrated definite changes of inflammation.

Both young men, Joshua and Michael, had ankylosing spondylitis. In one, the disease tore through the tissues like an unrelenting malignancy. In the other, the disease smoldered in place with only the subtlest of signs: MRI evidence of sacroiliac inflammation. Well, not quite. I had noticed that the left pupil was dilated slightly more than right, so I asked Michael if he had problems with the eye.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“You mean the iritis, which keeps coming back?” Sure. “My dad has the same thing. In fact, it’s the same eye. Weird, huh? But he’s lucky, he hasn’t ever had a shred of back pain. Lucky guy.”

Back to the Present Case

I re-entered the exam room and focused on the present task: Josh’s huge knee effusions. When I entered the right knee with a 16 gauge needle, there was so much pressure, my 50 cc syringe filled almost immediately. Joanne handed me another syringe, then another and another. Before I was done, six full syringes—300 cc—of amber fluid had been removed from the diseased knee. Another 250 cc was aspirated from the left knee, another record.

Even after the fluid had been aspirated from the knees, an audible grating, clunking sound occurred as I tried to flex and extend them. I hung up the films that Joshua had brought from Maine Medical Center. More bad news. From the pelvis to the neck, the spine was fused in a forward flexed position: a bamboo spine. The sacroiliac joints were fused. The hip joints were narrowed. For the first time in my practice career, I decided to admit a patient, an 18-year-old patient, for inflammatory arthritis.

In recent years, several studies have assessed whether altering the bacterial biome of the gut may lead to clinical improvement in ankylosing spondylitis. … But probiotics alone may not be the answer.

Ankylosing Spondylitis

This 48-year-old man with ankylosing spondylitis has marked restriction in cervical spine range of motion. The composite of the cervical, thoracic and lumbar spine radiographs show syndesmophytes bridging adjacent vertebrae throughout the spine.

This 48-year-old man with ankylosing spondylitis has marked restriction in cervical spine range of motion. The composite of the cervical, thoracic and lumbar spine radiographs show syndesmophytes bridging adjacent vertebrae throughout the spine.
ACR IMAGE BANK

Page: 1 2 3 4 5 6 7 8 9 10 11 12 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsOther Rheumatic Conditions Tagged with:Ankylosing SpondylitisArthritisBack paincase reportClinicalDiagnosisManagementMedicationoffice visitpatient carerheumatologistrheumatologyspineTreatment

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    May 20, 2022

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

    Anatomy Insider / shutterstock.com

    Gut Instinct: Ankylosing Spondylitis & the Microbiome

    October 3, 2019

    CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences